AZN

India's Wockhardt to supply millions of doses of COVID-19 vaccines to UK

Credit: REUTERS/DADO RUVIC

Indian drugmaker Wockhardt Ltd will supply millions of doses of multiple COVID-19 vaccines to the UK, including the one being developed by AstraZeneca and Oxford University, it said on Monday.

Adds details, background

BENGALURU, Aug 3 (Reuters) - Indian drugmaker Wockhardt Ltd WCKH.NS will supply millions of doses of multiple COVID-19 vaccines to the UK, including the one being developed by AstraZeneca AZN.L and Oxford University, it said on Monday.

The company has reserved fill-and-finish capacity - the final manufacturing step of putting vaccines into vials or syringes and packaging them - as part of an agreement with the UK government, it said.

Shares in Wockhardt jumped 10% after the news in a downcast Mumbai market. .BO

The UK government has also reserved one fill-and-finish production line at a Wockhardt subsidiary in Wrexham, Wales for its exclusive use for the next 18 months to secure supply.

More than 150 vaccines are being developed and tested around the world to stop the pandemic, with 25 in human clinical trials, according to the World Health Organization.

Coronavirus cases globally have crossed 18 million, including more than 688,000 deaths.

(Reporting by Sachin Ravikumar; Editing by Saumyadeb Chakrabarty)

((saisachin.r@tr.com; +91 80 6182 2754; Twitter: @sachinr27;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

AZN

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More